EMBL Conference: The Epitranscriptome
Date: | 20-Apr-16 to 22-Apr-16 |
Location: | EMBL Advanced Training Centre / Heidelberg / Germany |
Category: | Healthcare & Pharmaceuticals Conferences & Trade Fairs |
The regulation of the transcriptome is key to cellular processes that underpin cell biology, development and tissue function. All classes of cellular RNA are subject to posttranscriptional modification, be it by direct chemical modification, editing or non-templated nucleotide additions. Furthermore, regulatory RNA binding proteins and enzymes that can specifically recognize posttranscriptional RNA modifications have been identified. It is now emerging that the modification status of the transcriptome is dynamic and responsive to environmental/developmental cues. Together, this has elicited the realization of an ‘epitranscriptome’ where posttranscriptional RNA modification coupled with recruitment of effector RNA binding proteins dynamically regulates genomic output and RNA function. Importantly, mutations in core-regulators of the epitranscriptome are causative in many human diseases or congenital disorders.
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Breastfeeding News Today
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- Pharmaceutical Industry Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- SARS News Today
- Wellness News Today